Pfizer CEO Bourla on R&D, Obesity Drugs, and Winning Back Investors | At Barron's

Pfizer CEO Bourla on R&D, Obesity Drugs, and Winning Back Investors | At Barron'sПодробнее

Pfizer CEO Bourla on R&D, Obesity Drugs, and Winning Back Investors | At Barron's

Pfizer CEO on Sales, M&A, mRNA, Weight Loss DrugПодробнее

Pfizer CEO on Sales, M&A, mRNA, Weight Loss Drug

Former FDA Commissioner Dr. Scott Gottlieb on the rise of synthetic nicotineПодробнее

Former FDA Commissioner Dr. Scott Gottlieb on the rise of synthetic nicotine

Pharma investors should strategize trades around obesity drug offerings, says Grasso Global CEOПодробнее

Pharma investors should strategize trades around obesity drug offerings, says Grasso Global CEO

Covid will no longer be the epicenter of what we do, says Pfizer CEO Albert BourlaПодробнее

Covid will no longer be the epicenter of what we do, says Pfizer CEO Albert Bourla

New developments in weight-loss drugs: Novo Nordisk, Eli Lilly & Pfizer advance studiesПодробнее

New developments in weight-loss drugs: Novo Nordisk, Eli Lilly & Pfizer advance studies

Pfizer chairman and CEO Albert Bourla： Our oncology drugs will be blockbuster onesПодробнее

Pfizer chairman and CEO Albert Bourla： Our oncology drugs will be blockbuster ones

Final Trades: Corning, Apple, JPMorgan and the Russel 2000Подробнее

Final Trades: Corning, Apple, JPMorgan and the Russel 2000

Pfizer CEO Albert Bourla talks Q3 earnings results with Jim CramerПодробнее

Pfizer CEO Albert Bourla talks Q3 earnings results with Jim Cramer

Expectations for Pfizer have been low, says Mizuho's Jared Holz on weight-loss pill setbackПодробнее

Expectations for Pfizer have been low, says Mizuho's Jared Holz on weight-loss pill setback

Life Time CEO Bahram Akradi on Q4 earnings and GLP-1 weight-loss drugsПодробнее

Life Time CEO Bahram Akradi on Q4 earnings and GLP-1 weight-loss drugs

Nestle CEO Doesn't See Weight-Loss Drugs as Threat to BusinessПодробнее

Nestle CEO Doesn't See Weight-Loss Drugs as Threat to Business

Pfizer CEO on mRNA Vaccine Creation, R&D, Drug CostsПодробнее

Pfizer CEO on mRNA Vaccine Creation, R&D, Drug Costs

The Fitness Economy in the Age of OzempicПодробнее

The Fitness Economy in the Age of Ozempic

Baker Hughes Seeing Growth in Clean Energy and Fossil Fuel Demand: CEOПодробнее

Baker Hughes Seeing Growth in Clean Energy and Fossil Fuel Demand: CEO

The Growing Popularity of Compounded Weight-Loss DrugsПодробнее

The Growing Popularity of Compounded Weight-Loss Drugs

Weight-loss drug frenzy: $100 billion total addressable market opportunity?Подробнее

Weight-loss drug frenzy: $100 billion total addressable market opportunity?

How Our Obsession With Being Thin Is Driving Pharma ProfitsПодробнее

How Our Obsession With Being Thin Is Driving Pharma Profits

The Next 2 Obesity Drug Stocks? Plus, Bitcoin’s Bounce | Barron's StreetwiseПодробнее

The Next 2 Obesity Drug Stocks? Plus, Bitcoin’s Bounce | Barron's Streetwise

Популярное